Terra Energy & Resource Technolog.../ US88100A1016 /
28/12/2023 19:21:29 | Var. - | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0001USD | - | 114,000 Fatturato: 10 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0001 | 0.0001 |
GlobeNewswire
13:32
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire
13:31
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
GlobeNewswire
13:30
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire
13:30
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire
13:30
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire
13:30
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
13:30
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire
13:30
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
13:30
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
13:30
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire
13:26
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire
13:26
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire
13:10
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million